These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Pharmacokinetics of cefotaxime and desacetylcefotaxime in the newborn.
    Author: Aujard Y, Brion F, Jacqz-Aigrain E, Kasse MC, Chretien P, Criqui C, Mathieu H.
    Journal: Diagn Microbiol Infect Dis; 1989; 12(1):87-91. PubMed ID: 2653716.
    Abstract:
    A study of the pharmacokinetic parameters of cefotaxime (CTX) and desacetylcefotaxime (dCTX) in newborns was conducted; the former is commonly used for neonatal infections. The elimination half life of CTX correlated with gestational age (GA) and postnatal age (PNA). Elimination of dCTX was longer permitting a synergistic or additive effect with CTX against Gram-negative bacteria. CTX is indicated in the treatment of neonatal sepsis because of the increasing resistance of Escherichia coli to ampicillin and its good efficacy against group B streptococcus.
    [Abstract] [Full Text] [Related] [New Search]